although
potenti
mng
technolog
promis
evalu
studi
urgent
need
routin
clinic
use
within
reason
timefram
approach
describ
herein
crucial
bring
standard
ensur
qualiti
gener
sequenc
clinic
set
provid
easytous
singl
protocol
success
sinc
develop
next
generationsequenc
ng
technolog
use
metagenom
approach
grown
consider
consid
effici
unbias
tool
clinic
virolog
particular
character
viral
acut
respiratori
infect
ari
sever
advantag
metagenom
ng
mng
compar
convent
realtim
polymeras
chain
reaction
pcr
assay
highlight
firstli
full
viral
genet
inform
immedi
avail
allow
investig
respiratori
outbreak
viral
epidemiolog
surveil
identif
specif
mutat
lead
antivir
resist
higher
virul
secondli
signific
improv
viral
ari
diagnosi
report
process
sequenc
independ
mng
abl
identifi
highli
diverg
viral
genom
rare
respiratori
pathogen
discov
respiratori
virus
miss
target
pcr
control
ensur
qualiti
gener
sequenc
furthermor
specimen
specimen
environment
reagent
contamin
also
major
concern
metagenom
set
must
accur
evalu
object
studi
implement
qc
singl
metagenom
protocol
evalu
detect
broad
panel
dna
normal
pool
librari
vv
made
quantifi
use
univers
kapa
librari
quantif
kit
kapa
biosystem
wilmington
usa
phix
genom
ad
quantifi
librari
sequenc
illumina
nextseq
platform
fig
addit
notic
wetlab
process
design
prevent
contamin
much
possibl
reagent
store
prepar
dnafre
room
patient
sampl
open
laminar
flow
hood
prepcr
room
amplif
step
tube
handl
store
postpcr
room
stepwis
bioinformat
filter
pipelin
use
qualiti
filter
read
use
cutadapt
sickl
remov
human
archaeal
bacteri
fungal
sequenc
align
read
bwa
mem
databas
use
refseq
archaea
refseq
bacteria
refseq
fungi
remain
read
align
ezvir
viral
databas
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
particular
region
genom
latter
requir
could
import
correctli
identifi
rna
viru
subtyp
high
recombin
frequenc
within
speci
implement
specif
viral
famili
respiratori
specimen
spike
intern
qualiti
control
iqc
sampl
prepar
bacteriophag
commerci
kit
rna
intern
control
gene
select
iqc
posit
extern
qualiti
control
eqc
use
viral
transport
medium
spike
concentr
use
iqc
notempl
control
ntc
implement
evalu
contamin
process
statist
analys
perform
use
graphprism
version
appli
appropri
statist
test
associ
mng
viral
realtim
pcr
assay
determin
appli
pearson
correl
coeffici
differ
median
distribut
evalu
mannwhitney
u
test
pvalu
less
consid
statist
signific
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
determin
optim
intern
qualiti
control
spike
bacteriophag
singlestrand
rna
viru
ssrna
use
iqc
valid
whole
metagenom
process
sampl
order
optim
iqc
spike
level
sensit
metagenom
analysi
workflow
detect
first
evalu
tenfold
serial
dilut
nasopharyng
swab
test
neg
use
fa
rp
detect
intern
level
spike
ct
rang
dilut
ct
dilut
full
partial
genom
coverag
obtain
spike
level
intern
coverag
rang
dilut
dilut
highest
spike
level
total
number
viral
read
map
lowest
spike
level
fig
limit
number
ng
read
consum
iqc
detect
optim
spike
condit
determin
dilut
use
rest
studi
normal
read
count
significantli
lower
linear
dsdna
virus
viral
genom
type
fig
compar
viral
genom
type
notic
previous
describ
ebv
cmv
necessari
use
dnase
reduc
host
contamin
may
affect
fragil
larg
dsdna
virus
detect
limit
mng
analysi
mainli
depend
viral
load
total
number
read
per
sampl
effect
could
overcom
increas
sequenc
depth
howev
chose
limit
cost
workflow
reagent
cost
mng
approach
rel
low
estim
thank
viral
enrich
process
amplif
method
use
commerci
kit
dilut
use
univers
workflow
dna
rna
virus
also
reduc
reagent
cost
compar
metagenom
protocol
target
dna
rna
virus
separ
contrast
target
ng
specif
virus
follow
specif
amplif
pcr
time
cheaper
base
experi
eg
influenza
viru
sequenc
due
sever
limit
includ
cost
long
turnaround
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
time
viral
metagenom
current
consid
secondlin
approach
use
primari
routin
diagnost
tool
howev
improv
sequenc
technolog
allow
realtim
sequenc
minion
sequenc
oxford
nanopor
oxford
unit
kingdom
could
envis
mng
gradual
use
primari
diagnosi
midterm
case
high
viral
load
suffici
dna
input
amplif
workflow
might
use
minion
sequenc
approach
describ
preliminari
work
crucial
bring
standard
routin
clinic
use
mng
process
within
reason
timefram
copyright
holder
preprint
peerreview
authorfund
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
tabl
copyright
holder
preprint
peerreview
authorfund
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
